MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 2, 2004; DOI: 10.1124/mol.104.000224


0026-895X/04/6603-601-611$20.00
Mol Pharmacol 66:601-611, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.000224v1
66/3/601    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ennion, S. J.
Right arrow Articles by Seward, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ennion, S. J.
Right arrow Articles by Seward, E. P.

Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells

Steven J. Ennion, Andrew D. Powell, and Elizabeth P. Seward

Department of Cell Physiology and Pharmacology, University of Leicester, Leicester, United Kingdom (S.J.E.); Department of Pharmacology, University of Bristol, Bristol, United Kingdom (A.D.P.); and Department of Biomedical Sciences, University of Sheffield, Sheffield, United Kingdom (E.P.S.)

Nucleotides are released from bovine chromaffin cells and take part in a feedback loop to inhibit further exocytosis. To identify the nucleotide receptors involved, we measured the effects of a range of exogenous nucleotides and related antagonists on voltage-operated calcium currents (ICa), intracellular calcium concentration ([Ca2+]i), and membrane capacitance changes. In comparative parallel studies, we also cloned the bovine P2Y12 receptor from chromaffin cells and determined its properties by coexpression in Xenopus laevis oocytes with inward-rectifier potassium channels made up of Kir3.1 and Kir3.4. In both systems, the agonist order of potency was essentially identical (2-methylthio-ATP {approx} 2-methylthio-ADP >> ATP {approx} ADP > UDP). {alpha}{beta}-Methylene-ATP and adenosine were inactive. UTP inhibited ICa in chromaffin cells (pEC50 = 4.89 ± 0.11) but was essentially inactive at the cloned P2Y12 receptor. The relatively nonselective P2 antagonist pyridoxal-phosphate-6-azophenyl-2',4' disulfonic acid blocked nucleotide responses in both chromaffin cells and X. laevis oocytes, whereas the P2Y12- and P2Y13-selective antagonist N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-{beta},{gamma}-dichloromethylene ATP (ARC69931MX) blocked responses to ATP in both chromaffin cells and X. laevis oocytes but not to UTP in chromaffin cells. These results identify the P2Y12 purine receptor as a key component of the nucleotide inhibitory pathway and also demonstrate the involvement of a UTP-sensitive Gi/o -coupled pyrimidine receptor.


Received March 8, 2004; accepted May 28, 2004

Address correspondence to: Dr. Elizabeth P. Seward, Department of Biomedical Sciences, University of Sheffield, Alfred Denny Building, Western Bank, Sheffield, S10 2TN, United Kingdom. E-mail: e.p.seward{at}sheffield.ac.uk




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al.
International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics